A new study in the journal ACS Omega highlights patchouli oil’s potential far beyond its traditional fragrance role, positioning it as a credible active for next-generation botanical repellents.
Researchers developed a topical cream based on Pogostemon cablin (patchouli) essential oil and evaluated it against Aedes aegypti, the mosquito responsible for dengue, Zika and yellow fever transmission. Chemical profiling confirmed a classic patchouli chemotype, with patchouli alcohol as the dominant constituent.
In an arm-in-cage in vivo test, the formulation delivered up to 180 minutes of complete protection, putting it in a meaningful performance range for a natural-origin topical. Importantly for mechanism-driven formulation development, molecular docking showed key oil constituents binding to mosquito odorant-binding proteins (AaegOBP1 and AgamOBP1), with α-guaiene and β-elemene showing affinities comparable to DEET, suggesting a plausible olfactory disruption pathway rather than simple masking.
For fragrance and functional perfumery teams, the work reinforces patchouli oil’s dual relevance: a well-established olfactive material with emerging evidence as a bioactive platform ingredient for insect-repellent skin care and personal care applications.
The takeaway is straightforward: patchouli is increasingly being mapped as a functional active with measurable performance and a mechanistic story to match.
